STI Screening for Women Over 40: Updated Guidelines

Turning 40 usually reshuffles a woman's health checklist. Mammograms move up the list. Cholesterol panels get added. Bone density scans start getting mentioned at annual visits. STI screening, though, tends to quietly disappear from the conversation, almost as if risk expires on a birthday. It doesn't.

The numbers don't support that assumption. Chlamydia, gonorrhea, and syphilis diagnoses have all climbed among women in their 40s, 50s, and 60s over the past several years, partly because screening habits for this age group are inconsistent, and partly because providers assume older patients aren't sexually active or aren't at risk. New relationships after divorce, dating after widowhood, and long-term partnerships that open up later in life are all common in this decade. That's a population that's underscreened relative to its actual exposure.

At Lesbian STD, we hear a version of this story often: a woman in her 40s or 50s who has sex with women, told by a previous provider that she "probably didn't need" STI testing because pregnancy wasn't on the table. That advice skips over basic microbiology. If you want the full breakdown of what's recommended at each life stage, our STI Screening Schedule by Age: CDC Recommendations guide covers it in detail. This piece focuses specifically on what changes once you cross into your 40s.

What Is STI Screening, and Why Do the Rules Change After 40?

STI screening means testing done without a symptom present, based on age and risk factors rather than a specific complaint. That's different from diagnostic testing, which happens after you notice something, like unusual discharge or pelvic pain. Screening intervals and target infections shift with age, immune status, and reported risk behaviors, not just birthdate, and catching an infection during this window can reduce complications like pelvic inflammatory disease and long-term fertility problems down the line.

"Sexually active women age 25 and younger should be screened annually for chlamydia and gonorrhea, along with older women who have new or multiple partners, or a partner who has a sexually transmitted infection."

— Centers for Disease Control and Prevention

Evidence-based, medically reviewed guidance tends to converge on a few themes: chlamydia and gonorrhea screening narrows sharply after 25 unless risk factors are present, HIV screening stays recommended through age 64, and cervical cancer screening intervals lengthen for women with a clean screening history. We go into the reasoning behind those age brackets in our Annual STI Screening for Sexually Active Women article, but the short version is that risk, not age alone, should drive your screening plan. We built this guide to be respectful of diverse women's experiences, whether you've had the same partner for twenty years or you're dating again for the first time in a decade.

How Do Providers Decide Who Gets Screened for What?

Guidelines aren't handed down from a single meeting. Groups like the CDC and the American College of Obstetricians and Gynecologists (ACOG) review surveillance data, cost-effectiveness modeling, and outcomes research, then revise recommendations every few years as new evidence comes in. Nucleic acid amplification testing, the lab method used for chlamydia and gonorrhea, is sensitive enough to catch infections well before symptoms appear, a level of accuracy documented extensively in the peer-reviewed literature. That precision is exactly why screening intervals can be set by age and risk instead of guesswork.

What Are the CDC Guidelines for STI Screening?

The CDC recommends HIV screening at least once between ages 13 and 64, annual chlamydia and gonorrhea testing mainly for women under 25 or with new or multiple partners, and syphilis testing based on risk and pregnancy status. Women over 40 without new risk factors may need less frequent chlamydia and gonorrhea screening, but HIV testing and periodic panels remain appropriate well into your 60s.

Board-certified providers who follow these protocols look at risk factors, not birthdate, when building a screening plan. That matters especially for women who have sex with women, since HPV, herpes, trichomoniasis, and bacterial vaginosis can all pass skin to skin or through shared toys. As we cover in our Asymptomatic STI Detection: Why Testing Matters piece, most bacterial STIs produce no symptoms in women at all, which is exactly why age-based screening exists instead of waiting for a complaint to bring someone in.

What Are the ACOG Guidelines for STI Screening?

ACOG's guidance largely mirrors the CDC but adds exam-room detail: a risk assessment at every visit regardless of age, chlamydia screening extended past 25 for women with new or multiple partners, and an explicit reminder that screening decisions should account for the gender of a patient's partners rather than assuming heterosexual exposure by default.

Chlamydia screening for women 15 to 24 is the loudest recommendation in the guidelines, and for good reason. That age group carries the highest diagnosis rates. But the annual-screening default fades once you're past that window, which means the responsibility shifts partly onto you and your provider to flag risk factors out loud rather than expecting an automatic order. Action: ask directly whether your provider's screening plan accounts for partners of any gender, and don't assume it already does.

What STI Is Most Common in Your 40s?

HPV remains the most common STI across every adult age group, women over 40 included, though most infections clear on their own without ever causing a problem. Among reportable bacterial infections, chlamydia is still the most frequently diagnosed in this decade, followed by trichomoniasis and genital herpes, both of which can be carried silently for years before a diagnosis finally happens.

In our practice, we've seen patients in their 40s and 50s who assumed screening was something they'd simply aged out of, only to test positive for an infection they'd carried, unknowingly, for years. Trichomoniasis in particular is common and consistently underdiagnosed in women who have sex with women, since it doesn't always show up on the panels providers reach for by default.

Signs and Symptoms Women Over 40 Shouldn't Ignore

Some infections announce themselves clearly. Others don't. These are the signs worth a call to your provider rather than a wait-and-see approach:

• Unusual vaginal discharge that changes in color, smell, or thickness
• New or worsening pelvic pain, especially during sex or urination
• Sores, bumps, or blisters on the vulva, anus, or inner thighs
• Bleeding between periods or after sex, once your cycle has otherwise settled
• Persistent itching or irritation that doesn't resolve with your usual products
• Swollen or tender lymph nodes in the groin
• Burning during urination that isn't explained by a straightforward UTI diagnosis
• Unexplained fatigue paired with any of the symptoms above

Who Might Need a Different Screening Approach?

Not every woman over 40 needs the same testing menu, and pretending otherwise does a disservice to women whose risk is genuinely low. Women in a long-term, mutually monogamous relationship where both partners have tested negative may reasonably screen less often than someone dating multiple people. Women who've had a hysterectomy that removed the cervix for reasons unrelated to cervical dysplasia often don't need ongoing Pap testing at all, though that's worth confirming directly with a provider rather than assuming. Women who are immunocompromised, whether from HIV, transplant medication, or another condition, typically need more frequent screening than these general guidelines describe, not less.

"Most women can stop cervical cancer screening around age 65 if they've had adequate prior screening with normal results and aren't otherwise at high risk."

— Mayo Clinic

What Are the New Pap Smear Guidelines for 2026?

Current Pap and HPV co-testing guidance favors primary HPV testing every five years for women 30 to 65, or Pap and HPV co-testing every five years, over annual Pap testing alone. Women 21 to 29 still follow Pap testing every three years without routine HPV testing added in. The shift reflects that HPV testing alone tends to catch high-risk strains earlier than cytology by itself.

If you've had HPV testing as part of this screening and aren't sure what a positive or negative result actually means for your risk, our HPV Testing Results Explained article breaks down what each result implies and what typically happens next.

What to Expect After You Schedule Screening

Swab-based chlamydia and gonorrhea results usually come back within one to three days. Blood-based HIV and syphilis testing runs on a similar timeline, sometimes a little longer if your sample gets sent to an outside lab. Pap and HPV co-test results generally take one to two weeks. None of this is instant, and that's normal, not a sign something went wrong.

If a result comes back positive, treatment for chlamydia and gonorrhea is typically a single course of antibiotics. The CDC recommends retesting roughly three months later to confirm the infection actually cleared and wasn't picked back up from an untreated partner; we walk through the reasoning and timing for that follow-up in When Should You Get Retested After STI Treatment?

Practical Tips for Staying on Schedule After 40

1. Bring up your sexual history proactively at annual visits. Many providers stop asking once a patient is past her 20s.
2. Ask specifically whether your provider's screening plan accounts for partners of any gender, not just cisgender men.
3. Track your last Pap or HPV co-test date the way you track mammogram intervals, so five years doesn't quietly stretch to eight.
4. Get a baseline HIV test if you've never had one, even with a long, stable relationship history.
5. Ask about herpes testing directly if you've had symptoms. It isn't part of routine panels by default.
6. Pro tip: schedule your STI panel alongside your annual well-woman visit so it becomes routine instead of a separate appointment you have to remember to book.

Women over 40 deserve screening decisions built on their actual risk, not on assumptions about what a woman her age is supposedly doing in bed. Jenna Hardy and our clinical team put this guide together because too many patients in this age group have been waved off with a "you're probably fine" when a five-minute conversation about risk factors would have caught something treatable early. If it's been a while since your last STI panel, or you've never had one framed around your specific relationships, call our office, including our 24/7 line at (778) 804-3466 if you need to talk to someone after hours, and let's build a screening schedule that actually matches your life instead of a generic calendar.